Risk stratification by combining common genetic mutations and TERT promoter methylation in papillary thyroid cancer

ConclusionsThis study suggested that comprehensively analysis ofBRAF/RAS mutations,TERT promoter mutation and methylation is an effective strategy to identify high-risk patients with PTC.

http://link.springer.com/10.1007/s12020-024-03722-6

Source: Endocrine - February 14, 2024 Category: Endocrinology Source Type: research